abstract |
The present invention relates to compounds of formula (I) Formula I In this formula, R 1 , R 2 , R 3 , A 1 , A 2 , A 3 , A 4 and D have the meanings as described herein. The invention also relates to pharmaceutical compositions comprising such compounds and to therapeutic uses for cancer through the inhibition of mTOR and PI3K. |